These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 14566919

  • 1. Over-ruling a group sequential boundary--a stopping rule versus a guideline.
    Lan KK, Lachin JM, Bautista O.
    Stat Med; 2003 Nov 15; 22(21):3347-55. PubMed ID: 14566919
    [Abstract] [Full Text] [Related]

  • 2. Operating characteristics of sample size re-estimation with futility stopping based on conditional power.
    Lachin JM.
    Stat Med; 2006 Oct 15; 25(19):3348-65. PubMed ID: 16345019
    [Abstract] [Full Text] [Related]

  • 3. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
    Lachin JM.
    Clin Trials; 2009 Dec 15; 6(6):565-73. PubMed ID: 19933716
    [Abstract] [Full Text] [Related]

  • 4. A review of methods for futility stopping based on conditional power.
    Lachin JM.
    Stat Med; 2005 Sep 30; 24(18):2747-64. PubMed ID: 16134130
    [Abstract] [Full Text] [Related]

  • 5. Changing frequency of interim analysis in sequential monitoring.
    Lan KK, DeMets DL.
    Biometrics; 1989 Sep 30; 45(3):1017-20. PubMed ID: 2790114
    [Abstract] [Full Text] [Related]

  • 6. Implementing type I & type II error spending for two-sided group sequential designs.
    Rudser KD, Emerson SS.
    Contemp Clin Trials; 2008 May 30; 29(3):351-8. PubMed ID: 17933592
    [Abstract] [Full Text] [Related]

  • 7. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.
    Zhao Y, Grambsch PM, Neaton JD.
    Clin Trials; 2007 May 30; 4(2):140-53. PubMed ID: 17456513
    [Abstract] [Full Text] [Related]

  • 8. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ, Lipsky AM, Berry DA.
    Clin Trials; 2007 May 30; 4(1):5-14. PubMed ID: 17327241
    [Abstract] [Full Text] [Related]

  • 9. Two-stage clinical trial stopping rules.
    Elashoff JD, Reedy TJ.
    Biometrics; 1984 Sep 30; 40(3):791-5. PubMed ID: 6518247
    [Abstract] [Full Text] [Related]

  • 10. Construction of a continuous stopping boundary from an alpha spending function.
    Betensky RA.
    Biometrics; 1998 Sep 30; 54(3):1061-71. PubMed ID: 9750252
    [Abstract] [Full Text] [Related]

  • 11. Stopping clinical trials early for benefit: impact on estimation.
    Freidlin B, Korn EL.
    Clin Trials; 2009 Apr 30; 6(2):119-25. PubMed ID: 19342463
    [Abstract] [Full Text] [Related]

  • 12. Optimal continuous sequential boundaries for monitoring toxicity in clinical trials: a restricted search algorithm.
    Goldman AI, Hannan PJ.
    Stat Med; 2001 Jun 15; 20(11):1575-89. PubMed ID: 11391689
    [Abstract] [Full Text] [Related]

  • 13. Implementation of group sequential logrank tests in a maximum duration trial.
    Lan KK, Lachin JM.
    Biometrics; 1990 Sep 15; 46(3):759-70. PubMed ID: 2242413
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of experiments with adaptive interim analyses.
    Bauer P, Köhne K.
    Biometrics; 1994 Dec 15; 50(4):1029-41. PubMed ID: 7786985
    [Abstract] [Full Text] [Related]

  • 15. Increasing the sample size when the unblinded interim result is promising.
    Chen YH, DeMets DL, Lan KK.
    Stat Med; 2004 Apr 15; 23(7):1023-38. PubMed ID: 15057876
    [Abstract] [Full Text] [Related]

  • 16. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
    Kim K, Boucher H, Tsiatis AA.
    Biometrics; 1995 Sep 15; 51(3):988-1000. PubMed ID: 7548714
    [Abstract] [Full Text] [Related]

  • 17. Use of logrank tests and group sequential methods at fixed calendar times.
    DeMets DL, Gail MH.
    Biometrics; 1985 Dec 15; 41(4):1039-44. PubMed ID: 4096915
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.